4 Mg Topotecan Injection IP

Get a Price/Quote

MOQ : 1 Vial

4 Mg Topotecan Injection IP Specification

Indication
Small cell lung cancer, ovarian cancer, cervical cancer

Dosage Form
Injection

Salt Composition
Topotecan Hydrochloride 4 mg

Enzyme Types

Feature
Ready-to-use, single-use vial

Ingredients
Topotecan Hydrochloride, Water for Injection, Excipients

Application

Ph Level
3.9 4.2

Physical Color/Texture
Clear, pale yellow solution

Fermentation Smell
Odorless

Storage Instructions
Store below 25C, protect from light

Shelf Life
24 months

Route of Administration
Intravenous

Compatibility
Compatible with common IV fluids (consult leaflet)

Strength
4 mg/4 mL

Disposal Instructions
Dispose of unused product as per hazardous waste protocol

Warning
To be administered by healthcare professionals only

Regulatory Approval
IP (Indian Pharmacopoeia) certified

Packaging Type
Box packaging

Container Type
Glass vial

Reconstitution Needed
No (ready to use)

Prescription/Non-prescription
Prescription

About 4 Mg Topotecan Injection IP

Experience top-rated oncology care with 4 Mg Topotecan Injection IP, a popular and acclaimed chemotherapeutic solution for small cell lung, ovarian, and cervical cancers. This monumental, ready-to-use glass vial, containing Topotecan Hydrochloride 4 mg/4 mL, is championed for its stellar efficacy and regulatory approval (IP certified). Packaged securely in a box, this prescription-only injection is for intravenous administration by healthcare professionals. It boasts compatibility with most IV fluids and requires no reconstitution. Each pale yellow, odorless solution meets the highest standards for export markets, offering a robust 24-month shelf life and compliance with hazardous waste protocols.

Advanced Application: Superior Features and Methodology

4 Mg Topotecan Injection IP is administered intravenously, ensuring precise delivery directly into the bloodstream. Its ready-to-use design eliminates reconstitution steps, promoting swift, safe, and reliable application in oncology settings. Composed of Topotecan Hydrochloride and other excipients, the clear, pale yellow solution is single-use, enhancing safety and minimizing contamination risks. Specifically engineered for small cell lung, ovarian, and cervical cancers, this product is intended for use exclusively by healthcare professionals on the surface of intravenous access points, guaranteeing effective chemotherapy administration.

Sample Policy, Certification, and Supply Ability Highlights

Our 4 Mg Topotecan Injection IP echoes confidence in export markets with a robust sample exchange policy and reliable supply capacity. This IP-certified product ensures that each outlay reaches you with verified quality and compliance. We cater to international distributors, exporters, suppliers, and traders across India, facilitating seamless market access. Trust in our acclaimed product-fully certified and supported by a transparent supply network-to meet the critical needs of healthcare professionals and their patients worldwide.

FAQ's of 4 Mg Topotecan Injection IP:

Q: How is 4 Mg Topotecan Injection IP administered to patients?

A: This injection is delivered intravenously by healthcare professionals, ensuring direct and precise drug delivery into the patient's bloodstream during oncology treatment.

Q: What cancers is this Topotecan Injection indicated for?

A: 4 Mg Topotecan Injection IP is primarily indicated for small cell lung cancer, ovarian cancer, and cervical cancer as part of established chemotherapy protocols.

Q: When should this injection be used and by whom?

A: It should only be used following a physician's prescription and administered by qualified healthcare professionals in a clinical setting.

Q: What are the special features of this product?

A: This ready-to-use, single-use vial is compatible with popular IV fluids, requires no reconstitution, is odorless, and maintains stability for up to 24 months if stored correctly.